CSI Market
Sign In | Register

Clearpoint Neuro Inc (CLPT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CLPT Annual Cash Flow →
Quarterly cash flow trends provide additional context on Clearpoint Neuro Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-20.89
Depreciation & amortization1.48
Amortization of Other Assets1.10
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed-0.10
Increase (Decrease) in Inventories0.45
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation4.49
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest1.06
Derivative Gain Loss On Derivative Net-
Other Cost And Expense Operating-
Derivative Gain Loss On Derivative Net-
Increase Decrease In Lease Liabilities-
Lease Liabilities-
Increase Decrease In Operating Lease Liability-0.39
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.75
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.78
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.34
Other Working Capital0.22
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-4.98
Discontinued operations0.00
Net Cash flow from Operating Activities-14.98
Investing Activities
Capital Expenditures-0.86
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Acquisition Of Licensing Rights-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.86
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.15
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-1.99
Other net0.00
Proceeds From Issuance Of Equity Private Placement-
Repayments Of Secured Debt-
Prepayment Of Offering Costs-
Stock Issued During Period Value New Issues-
Proceeds From Issuance Of Paycheck Protection Program Loan-
Proceeds From Stock Option And Warrant Exercises-
Payment Of At The Market Offering Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents46.97
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.84
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-15.84
Total Cash Flow-16.69
4 historic quarters locked

Sign in to unlock the full Clearpoint Neuro Inc cash flow history.

Sign In Create Free Account

About Clearpoint Neuro Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-330842

Figures are derived from filed reports and may be restated. Historical data is subject to revision.